These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31323799)

  • 1. Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization.
    Sammour RMF; Taher M; Chatterjee B; Shahiwala A; Mahmood S
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31323799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Different Carriers on In Vitro and In Vivo Drug Release Behavior of Aceclofenac Proniosomes.
    Sammour RMF; Chatterjee B; Taher M; Saleh MSM; Shahiwala A
    Curr Drug Deliv; 2021; 18(9):1272-1279. PubMed ID: 33605859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and
    Mujtaba MA; Kaleem M; Chaware R; Ingole A; Asiri YI; Hassan MZ; Sabale V; Sabale P; Anwer MK; Mahmood D; Aldawsari MF
    ACS Omega; 2024 Apr; 9(14):16346-16357. PubMed ID: 38617636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations.
    Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT
    Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maltodextrin-based proniosomes.
    Blazek-Welsh AI; Rhodes DG
    AAPS PharmSci; 2001; 3(1):E1. PubMed ID: 11741252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol proniosomes as a convenient nanoingredient for functional food.
    Schlich M; Lai F; Pireddu R; Pini E; Ailuno G; Fadda AM; Valenti D; Sinico C
    Food Chem; 2020 Apr; 310():125950. PubMed ID: 31830712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and characterization of catechin-loaded proniosomes for food fortification.
    Shruthi PA; Pushpadass HA; Magdaline Eljeeva Emerald F; Surendra Nath B; Laxmana Naik N
    J Sci Food Agric; 2021 Apr; 101(6):2439-2448. PubMed ID: 33027542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes.
    Blazek-Welsh AI; Rhodes DG
    Pharm Res; 2001 May; 18(5):656-61. PubMed ID: 11465422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
    Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN
    Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced oral bioavailability of isradipine via proniosomal systems.
    Veerareddy PR; Bobbala SK
    Drug Dev Ind Pharm; 2013 Jun; 39(6):909-17. PubMed ID: 22998221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation.
    Alshora D; Ibrahim M; Alanazi N; Alowyid M; Ali Alnakhli Z; Mohammed Alshiban N; Maodaa S; Alyami NM; Alotaibi I
    Saudi Pharm J; 2023 Dec; 31(12):101830. PubMed ID: 38028219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.
    Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K
    Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering 5-flourouracil and leucovorin-loaded vesicular systems for possible colon specific delivery:
    Ugorji OL; Onyishi IV; Chukwu A; Attama AA
    Heliyon; 2024 Apr; 10(8):e28872. PubMed ID: 38655322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of pharmacosomes of aceclofenac.
    Semalty A; Semalty M; Rawat BS; Singh D; Rawat MS
    Indian J Pharm Sci; 2010 Sep; 72(5):576-81. PubMed ID: 21694988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
    Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
    Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.